Novo Nordisk A/S Common Stock (NVO)
EBITDA Growth
-11.28%
Quarterly · Period ending:
NVO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-11.28%period ending
Latest reported-11.28%period ending
NVO Quarterly EBITDA YoY % (2.91% → -11.28%)
Year-over-year change
High-resolution chart · PNG
NVO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -11.2786% | |
| 50.2997% | |
| -13.307% | |
| -10.9249% | |
| 21.9844% | |
| 24.7656% | |
| 60.8081% | |
| 14.0402% | |
| 33.7938% | |
| 33.8241% | |
| 199.9579% | |
| 37.6418% | |
| 23.1933% | |
| 31.28% | |
| -31.1631% | |
| 36.8645% | |
| 34.3932% | |
| 15.9839% | |
| 18.2698% | |
| 15.1523% | |
| 6.8972% | |
| 4.0621% | |
| 22.6881% | |
| 0.4591% | |
| 3.5398% | |
| 13.6839% | |
| -11.2148% | |
| 19.3315% | |
| 4.0397% | |
| 6.4821% | |
| 10.6774% | |
| -1.2078% | |
| -4.4922% | |
| -0.5396% | |
| -16.8041% | |
| -3.086% | |
| 11.0186% | |
| 11.5776% | |
| 88.38% | |
| 4.2307% | |
| 0.6398% | |
| -12.489% | |
| -25.2028% | |
| 25.2431% | |
| 34.0343% | |
| 59.6054% | |
| 3.2109% | |
| 11.3222% | |
| 1.7872% | |
| 8.2633% | |
| 23.2522% | |
| 15.1195% | |
| 23.4004% | |
| 33.209% | |
| 6.7565% | |
| 36.433% | |
| 40.9033% | |
| 16.9029% | |
| -1.8713% | |
| 0.4181% | |
| -4.2056% | |
| 8.0306% | |
| 89.2824% | |
| 28.3255% | |
| 20.9293% | |
| 12.5774% | |
| -4.2017% | |
| 25.224% | |
| 67.7481% | |
| 39.8022% | |
| 196.9648% | |
| 33.3109% | |
| 1.33% | |
| 39.3813% | |
| -45.255% | |
| 7.1843% | |
| 6.7677% | |
| -1.274% | |
| 9.7671% | |
| 8.3335% | |
| 12.2786% | |
| 55.5794% | |
| 4.3742% | |
| 32.507% | |
| 24.1327% | |
| 0.0692% | |
| 118.4991% | |
| -69.2469% | |
| -65.5439% | |
| -70.4884% | |
| 20.6164% | |
| -12.1471% | |
| 3.861% | |
| -14.9829% | |
| -7.5909% | |
| -3.1034% | |
| -8.1313% | |
| 12.606% | |
| 19.3614% | |
| -56.6485% |